Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized Trial.
Chest. 2022 Mar;161(3):781-790. doi: 10.1016/j.chest.2021.09.037. Epub 2021 Oct 8.
Chest. 2022.
PMID: 34627853
Clinical Trial.